Two newly approved centers, located in Camposampiero and Florence, have completed their first commercial implants of the Argus II Retinal Prosthesis System (Argus II), says the system's manufacturer, Second Sight Medical Products, Inc. The patients are suffering from outer retinal degeneration.
Outer retinal degeneration is the deterioration of the outer layer of the retina caused by progressive death of the cells in this region of the retina. An important type of outer retinal degeneration is Retinitis Pigmentosa (RP). To date, surgeons have implanted the specialty lens in more than 100 individuals worldwide. The system stimulates the remaining cells of the retina with electrical pulses. These firing cells create light patterns in the brain. The company says these images help with such daily activities as recognizing shapes and large objects, locating people, identifying the location of doorways, and following lines or edges.
The treatment is offered at approved centers in Canada, France,
Germany, Italy, Netherlands, Saudi Arabia, Spain, Switzerland, Turkey,
United Kingdom, and the United States. Read more.